← Leaderboards
Jerry Ingrande
Stanford University
$991,440
Attributed
$991,440
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $198.3K · FY2011–15$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$991,440 · 1
By mechanism
K23$991,440 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Angela J Rogers$4,189,964
- Georgios Skiniotis$19,731,539
- Tushar Jasubhai Desai$6,715,037
- William T Jackson$6,237,661
- M Bruce Maciver$3,496,202
Others in their field
Top investigators on “Adipocyte Differentiation”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$21,612,487
- Evan D Rosen · Dana-Farber Cancer Institute$18,089,164
- C Ronald Kahn · Joslin Diabetes Center$15,763,544
- Hei Sook Sul · University Of California Berkeley$14,899,678
- Patrick Seale · Dana-Farber Cancer Inst$13,511,848
- Ormond A Macdougald · University Of Michigan At Ann Arbor$13,150,120
Research focus
Adipocyte DifferentiationAdipocytesAdiponectinAdipose TissueAffectAnesthesia ProceduresAnestheticsAnti-InflammatoryAnti-Inflammatory AgentsAtherosclerosisBiopsyBlood SpecimenCardiacCardiovascular PhysiologyCohortCoronary ArteriosclerosisCytochrome P450Cytochrome P450 3a4DoseDrug DistributionDrug KineticsDrug MetabolismDrug Or Chemical Tissue DistributionAccounting
Grant awards (5)
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity$198,288
K23 · FY2015 · GM · contact PI
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity$198,288
K23 · FY2014 · GM · contact PI
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity$198,288
K23 · FY2013 · GM · contact PI
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity$198,288
K23 · FY2012 · GM · contact PI
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity$198,288
K23 · FY2011 · GM · contact PI